Logo image of CSR

CENTERSPACE (CSR) Stock Fundamental Analysis

NYSE:CSR - US15202L1070 - REIT

59.5 USD
+0.78 (+1.33%)
Last: 8/29/2025, 5:05:00 PM
59.5 USD
0 (0%)
After Hours: 8/29/2025, 5:05:00 PM
Fundamental Rating

2

Overall CSR gets a fundamental rating of 2 out of 10. We evaluated CSR against 20 industry peers in the Residential REITs industry. Both the profitability and financial health of CSR have multiple concerns. CSR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CSR has reported negative net income.
In the past year CSR had a positive cash flow from operations.
In the past 5 years CSR reported 4 times negative net income.
In the past 5 years CSR always reported a positive cash flow from operatings.
CSR Yearly Net Income VS EBIT VS OCF VS FCFCSR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

CSR has a worse Return On Assets (-1.47%) than 85.00% of its industry peers.
With a Return On Equity value of -4.09%, CSR is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
CSR's Return On Invested Capital of 0.99% is on the low side compared to the rest of the industry. CSR is outperformed by 85.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CSR is in line with the industry average of 2.61%.
The 3 year average ROIC (0.95%) for CSR is below the current ROIC(0.99%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.47%
ROE -4.09%
ROIC 0.99%
ROA(3y)-0.08%
ROA(5y)-0.14%
ROE(3y)-0.29%
ROE(5y)-0.39%
ROIC(3y)0.95%
ROIC(5y)0.7%
CSR Yearly ROA, ROE, ROICCSR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

The Operating Margin of CSR (9.21%) is worse than 85.00% of its industry peers.
CSR's Operating Margin has improved in the last couple of years.
CSR has a Gross Margin (57.86%) which is comparable to the rest of the industry.
CSR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.21%
PM (TTM) N/A
GM 57.86%
OM growth 3Y90.72%
OM growth 5Y6.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.32%
CSR Yearly Profit, Operating, Gross MarginsCSR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

0

2. Health

2.1 Basic Checks

CSR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CSR has more shares outstanding
CSR has more shares outstanding than it did 5 years ago.
CSR has a worse debt/assets ratio than last year.
CSR Yearly Shares OutstandingCSR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CSR Yearly Total Debt VS Total AssetsCSR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 0.15, we must say that CSR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.15, CSR is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.54 is on the high side and indicates that CSR has dependencies on debt financing.
The Debt to Equity ratio of CSR (1.54) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Altman-Z 0.15
ROIC/WACC0.15
WACC6.41%
CSR Yearly LT Debt VS Equity VS FCFCSR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.22 indicates that CSR may have some problems paying its short term obligations.
CSR's Current ratio of 0.22 is on the low side compared to the rest of the industry. CSR is outperformed by 65.00% of its industry peers.
CSR has a Quick Ratio of 0.22. This is a bad value and indicates that CSR is not financially healthy enough and could expect problems in meeting its short term obligations.
CSR's Quick ratio of 0.22 is on the low side compared to the rest of the industry. CSR is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
CSR Yearly Current Assets VS Current LiabilitesCSR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

The earnings per share for CSR have decreased strongly by -78.46% in the last year.
CSR shows a small growth in Revenue. In the last year, the Revenue has grown by 3.44%.
CSR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.03% yearly.
EPS 1Y (TTM)-78.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.05%
Revenue 1Y (TTM)3.44%
Revenue growth 3Y8.97%
Revenue growth 5Y7.03%
Sales Q2Q%5.39%

3.2 Future

CSR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.30% yearly.
CSR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.54% yearly.
EPS Next Y58.65%
EPS Next 2Y37.72%
EPS Next 3Y37.3%
EPS Next 5YN/A
Revenue Next Year4.6%
Revenue Next 2Y3.8%
Revenue Next 3Y3.54%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CSR Yearly Revenue VS EstimatesCSR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
CSR Yearly EPS VS EstimatesCSR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CSR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CSR Price Earnings VS Forward Price EarningsCSR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CSR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.5
CSR Per share dataCSR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

A more expensive valuation may be justified as CSR's earnings are expected to grow with 37.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.72%
EPS Next 3Y37.3%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.43%, CSR is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.79, CSR pays a bit more dividend than its industry peers.
CSR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 5.43%

5.2 History

The dividend of CSR decreases each year by -0.65%.
CSR has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of CSR decreased recently.
Dividend Growth(5Y)-0.65%
Div Incr Years1
Div Non Decr Years1
CSR Yearly Dividends per shareCSR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

The earnings of CSR are negative and hence is the payout ratio. CSR will probably not be able to sustain this dividend level.
DP-173.83%
EPS Next 2Y37.72%
EPS Next 3Y37.3%
CSR Yearly Income VS Free CF VS DividendCSR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

CENTERSPACE

NYSE:CSR (8/29/2025, 5:05:00 PM)

After market: 59.5 0 (0%)

59.5

+0.78 (+1.33%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners87.73%
Inst Owner Change0.08%
Ins Owners0.37%
Ins Owner Change4.31%
Market Cap997.22M
Analysts78.67
Price Target68.39 (14.94%)
Short Float %1.15%
Short Ratio1.73
Dividend
Industry RankSector Rank
Dividend Yield 5.43%
Yearly Dividend3.24
Dividend Growth(5Y)-0.65%
DP-173.83%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-27 2025-06-27 (0.77)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)39.65%
Min EPS beat(2)-22.37%
Max EPS beat(2)101.68%
EPS beat(4)1
Avg EPS beat(4)-11.61%
Min EPS beat(4)-76.02%
Max EPS beat(4)101.68%
EPS beat(8)3
Avg EPS beat(8)-25.91%
EPS beat(12)6
Avg EPS beat(12)497.96%
EPS beat(16)8
Avg EPS beat(16)374.71%
Revenue beat(2)1
Avg Revenue beat(2)-0.18%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)0.01%
Revenue beat(4)1
Avg Revenue beat(4)-1.36%
Min Revenue beat(4)-4.79%
Max Revenue beat(4)0.01%
Revenue beat(8)1
Avg Revenue beat(8)-1.33%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)-0.1%
PT rev (1m)-4.89%
PT rev (3m)-5.4%
EPS NQ rev (1m)9.38%
EPS NQ rev (3m)-190%
EPS NY rev (1m)10.34%
EPS NY rev (3m)17.89%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)0.68%
Revenue NY rev (1m)0.49%
Revenue NY rev (3m)0.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.73
P/FCF N/A
P/OCF 9.81
P/B 1.38
P/tB 1.38
EV/EBITDA 15.5
EPS(TTM)-0.93
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-5.09
FCFYN/A
OCF(TTM)6.07
OCFY10.2%
SpS15.94
BVpS43.04
TBVpS43.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.47%
ROE -4.09%
ROCE 1.26%
ROIC 0.99%
ROICexc 1%
ROICexgc 1.02%
OM 9.21%
PM (TTM) N/A
GM 57.86%
FCFM N/A
ROA(3y)-0.08%
ROA(5y)-0.14%
ROE(3y)-0.29%
ROE(5y)-0.39%
ROIC(3y)0.95%
ROIC(5y)0.7%
ROICexc(3y)0.95%
ROICexc(5y)0.71%
ROICexgc(3y)0.96%
ROICexgc(5y)0.71%
ROCE(3y)1.2%
ROCE(5y)0.89%
ROICexcg growth 3Y107.93%
ROICexcg growth 5Y7.08%
ROICexc growth 3Y107.97%
ROICexc growth 5Y7.04%
OM growth 3Y90.72%
OM growth 5Y6.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.32%
F-Score2
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Debt/EBITDA 8.27
Cap/Depr 170.32%
Cap/Sales 70%
Interest Coverage 0.74
Cash Conversion 75.67%
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z 0.15
F-Score2
WACC6.41%
ROIC/WACC0.15
Cap/Depr(3y)101.15%
Cap/Depr(5y)179.12%
Cap/Sales(3y)41.21%
Cap/Sales(5y)77.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-78.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.05%
EPS Next Y58.65%
EPS Next 2Y37.72%
EPS Next 3Y37.3%
EPS Next 5YN/A
Revenue 1Y (TTM)3.44%
Revenue growth 3Y8.97%
Revenue growth 5Y7.03%
Sales Q2Q%5.39%
Revenue Next Year4.6%
Revenue Next 2Y3.8%
Revenue Next 3Y3.54%
Revenue Next 5YN/A
EBIT growth 1Y-5.28%
EBIT growth 3Y107.82%
EBIT growth 5Y14.31%
EBIT Next Year451.97%
EBIT Next 3Y81.11%
EBIT Next 5YN/A
FCF growth 1Y-42.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.34%
OCF growth 3Y5.35%
OCF growth 5Y7.14%